• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

Corresponding author: xuyi, xuyi999999999@163.com
DOI: 10.12201/bmr.202511.00050
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: [abstract missed]

    Key words:

    Submit time: 19 November 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • HONG Suru, WU Xiayang. Exploring the Molecular Mechanism of Fengliao Changweikang in the Treatment of Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology. 2025. doi: 10.12201/bmr.202504.00022

    liujinsong. . 2025. doi: 10.12201/bmr.202509.00047

    姚雨, QnRui. . 2025. doi: 10.12201/bmr.202501.00023

    wangyixuan, wusiyi, fangyue, zhoulushan, songxiaobo, leilei, chenxiaofei, dingcaifei, wangchenye. . 2024. doi: 10.12201/bmr.202407.00047

    tanmeixiu. . 2025. doi: 10.12201/bmr.202508.00036

    . 2025. doi: 10.12201/bmr.202506.00084

    yinyongqin, hedongmei. On the Treatment of Perimenopausal Syndrome Based on the Yuanqi Theory. 2025. doi: 10.12201/bmr.202507.00017

    Zhang Bo, Zhu Ying, Chen Zheng. . 2025. doi: 10.12201/bmr.202511.00006

    Liu Zhanli. . 2025. doi: 10.12201/bmr.202506.00075

    XuHong. Advances in the treatment of osteopenia-seropathic obesity syndrome in the elderly. 2024. doi: 10.12201/bmr.202411.00064

  • ID Submit time Number Download
    1 2025-09-26

    10.12201/bmr.202511.00050V1

    Download
  • Public  Anonymous  To author only

Get Citation

hanyuyin, liuli, xuyi. [title missed]. 2025. biomedRxiv.202511.00050

Article Metrics

  • Read: 206
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误